Skip to main content
Clinical Trials/NCT01327365
NCT01327365
Unknown
Phase 2

Trans-Radial Percutaneous Coronary Interventions Using a Sheathless Guiding Catheter-Based Approach

University Hospital, Geneva1 site in 1 country250 target enrollmentAugust 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
University Hospital, Geneva
Enrollment
250
Locations
1
Primary Endpoint
Procedural success
Last Updated
13 years ago

Overview

Brief Summary

Background:

The transradial approach is increasingly used in percutaneous coronary intervention (PCI) because of lower major access site complications, lower bleeding risk and earlier patient mobilization. According to this trend, in the last couple of years at the University Hospital of Geneva the investigators have changed their practice and currently the transradial approach is the most frequently used for PCI. However, the small diameter of the radial artery remains a major limitation of the technique, especially in women or for complex PCI necessitating larger bore guiding catheters. This may be overcome with sheathless guiding catheters (Asahi, Japan), allowing for a standard inner catheter diameter (6-7 Fr), with an outer diameter equivalent to a standard 5 and 6 Fr introducer sheath.

Aim:

This study is aimed to compare the transradial approach for PCI with a sheathless guiding catheter and with a standard guiding catheter in women and patients with complex lesion necessitating large bore guiding catheters.

Material and methods:

This prospective study will consecutively randomize all women and all men with bifurcation/ostial lesion of a major coronary vessel (i.e. ≈ 120/year) in whom a transradial PCI is attempted. The procedures will be performed either with a standard 6 or 7Fr guiding catheter or with the sheathless 6.5, 7.5 Fr catheters.

End-points:

Successful performance a transradial PCI in all consecutive patients which qualify according to the inclusion criteria (technical feasibility). Establish the proportion of procedures performed with no device-related complications (safety). Analyze in details the technical aspects of the sheathless catheter (efficacy).

Sample size:

The investigators have planed to include in the study ≈ 250 patients in two years. After 1 year of enrollment the investigators will perform an interim analysis and the instigators will decide at that moment, according to the observed end-points, if prolonging the study would be of any scientific value. In this case another 100 patients will be further included in the study.

Enrollment time:

The investigators will start the study as soon the local ethical committee will give us the permission. The investigators plan to start the study in July 2010. The end is expected for July 2012.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
September 2013
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Robert F Bonvini

MD

University Hospital, Geneva

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who refused to give their written informed consent.
  • Male patients, in whom PCI can be easily performed with a 6 Fr standard guiding catheter (i.e. no bifurcation or ostial lesion).
  • Patients in whom the radial approach is contra-indicated:
  • Patients with a dialysis arteria-venous fistula or in whom an arteria-venous fistula is planed in the future.
  • Patients with a known radial artery occlusion.
  • Patients in whom a radial approach was unsuccessfully already attempted in the past (anamnestic notion or previous medical record) secondary to a:
  • Challenging vessel anatomy,
  • Vessel tortuosity,
  • Known impossibility to cannulate the coronary ostia by the radial approach.
  • Patients in whom the Allen test results pathological bilaterally:

Outcomes

Primary Outcomes

Procedural success

Time Frame: baseline

Procedural success, defined as a successful delivery of the stent using the sheathless guding catheter, in consecutive patients according to the inclusion criteria (women and bifurcation/ostial lesions) = technical feasibility of the sheathless catheter.

Procedural safety

Time Frame: +24 hours

Procedural safety, defined as the proportion of procedures performed in the absence of device-related complications (= safety of the sheathless catheter).

Secondary Outcomes

  • Safety and Tolerability(baseline)
  • safety and tolerability(+24 hours)

Study Sites (1)

Loading locations...

Similar Trials